- Report
- July 2022
- 255 Pages
Global
From €4074EUR$4,450USD£3,462GBP
- Report
- January 2022
- 60 Pages
Global
From €3616EUR$3,950USD£3,073GBP
- Report
- December 2023
- 142 Pages
Brazil
From €2289EUR$2,500USD£1,945GBP
- Report
- May 2018
- 106 Pages
Global
From €3204EUR$3,500USD£2,723GBP
- Report
- April 2025
- 85 Pages
Saudi Arabia
From €3204EUR$3,500USD£2,723GBP
- Report
- January 2025
- 82 Pages
Vietnam
From €3204EUR$3,500USD£2,723GBP
- Report
- December 2024
- 85 Pages
Spain
From €3204EUR$3,500USD£2,723GBP
- Report
- September 2024
- 80 Pages
Japan
From €3204EUR$3,500USD£2,723GBP
- Report
- September 2024
- 80 Pages
France
From €3204EUR$3,500USD£2,723GBP
- Report
- August 2024
- 80 Pages
Japan
From €3204EUR$3,500USD£2,723GBP
- Report
- April 2024
- 185 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- April 2024
- 185 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- April 2024
- 187 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- October 2023
- 133 Pages
Europe
From €3662EUR$4,000USD£3,112GBP
- Report
- October 2023
- 138 Pages
Asia Pacific
From €3662EUR$4,000USD£3,112GBP
- Report
- October 2023
- 177 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- October 2023
- 190 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- October 2023
- 182 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- October 2023
- 190 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- October 2023
- 182 Pages
Global
From €4119EUR$4,500USD£3,501GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more